XML 69 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – Revenue Recognition, Balances Reported with and without Adoption of ASC 606 (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jan. 01, 2018
Consolidated Statements of Income                        
Net sales $ 685,028 $ 665,775 $ 710,608 $ 703,350 $ 625,895 $ 624,326 $ 617,746 $ 601,316 $ 2,764,761 $ 2,469,283 $ 2,330,934  
Costs and Expenses                        
Cost of sales                 1,812,961 1,603,070 1,496,174  
Provision for income taxes                 71,254 74,796 74,893  
Net income 40,675 $ 39,022 $ 55,781 $ 59,288 49,506 $ 53,529 $ 65,189 $ 51,805 194,766 220,029 205,604  
Assets                        
Accounts and note receivable 569,630       510,426       569,630 510,426    
Inventories 381,110       337,216       381,110 337,216   $ 330,152
Prepaid and other 118,245       109,791       118,245 109,791   116,202
Liabilities                        
Accounts payable and accrued liabilities 525,199       461,579       525,199 461,579   455,873
Deferred income taxes 53,917       20,995       53,917 20,995   22,287
Deferred and other non-current liabilities 23,465       5,608       23,465 5,608   6,432
Stockholders' Equity                        
Retained earnings 1,371,826       $ 1,301,147       1,371,826 1,301,147   1,304,084
Beauty + Home                        
Consolidated Statements of Income                        
Net sales                 1,426,382 1,313,786 1,261,086  
Pharma                        
Consolidated Statements of Income                        
Net sales                 954,652 805,880 741,473  
Food + Beverage                        
Consolidated Statements of Income                        
Net sales                 383,727 $ 349,617 $ 328,375  
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09                        
Costs and Expenses                        
Cost of sales                 1,811,290      
Provision for income taxes                 71,541      
Net income                 195,588      
Assets                        
Inventories 391,315               391,315      
Prepaid and other 108,490               108,490      
Liabilities                        
Accounts payable and accrued liabilities 529,168               529,168      
Deferred income taxes 52,912               52,912      
Deferred and other non-current liabilities 23,066               23,066      
Stockholders' Equity                        
Retained earnings 1,369,711               1,369,711      
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Beauty + Home                        
Consolidated Statements of Income                        
Net sales                 1,424,701      
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Pharma                        
Consolidated Statements of Income                        
Net sales                 954,497      
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Food + Beverage                        
Consolidated Statements of Income                        
Net sales                 385,001      
Adjustment/Effect of Change | Accounting Standards Update 2014-09                        
Costs and Expenses                        
Cost of sales                 1,671      
Provision for income taxes                 (287)      
Net income                 (822)      
Assets                        
Inventories (10,205)               (10,205)     (7,064)
Prepaid and other 9,755               9,755     6,411
Liabilities                        
Accounts payable and accrued liabilities (3,969)               (3,969)     (5,706)
Deferred income taxes 1,005               1,005     1,292
Deferred and other non-current liabilities 399               399     824
Stockholders' Equity                        
Retained earnings $ 2,115               2,115     $ 2,937
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Beauty + Home                        
Consolidated Statements of Income                        
Net sales                 1,681      
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Pharma                        
Consolidated Statements of Income                        
Net sales                 155      
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Food + Beverage                        
Consolidated Statements of Income                        
Net sales                 $ (1,274)